Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quanterix Corp
(NQ:
QTRX
)
14.89
+0.49 (+3.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
306,994
Open
14.53
Bid (Size)
14.56 (1)
Ask (Size)
15.22 (1)
Prev. Close
14.40
Today's Range
14.21 - 15.05
52wk Range
11.82 - 29.70
Shares Outstanding
38,063,618
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
June 17, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
June 05, 2024
From
Quanterix Corporation
Via
Business Wire
Performance
YTD
-45.16%
-45.16%
1 Month
+16.06%
+16.06%
3 Month
-8.65%
-8.65%
6 Month
-34.75%
-34.75%
1 Year
-36.50%
-36.50%
More News
Read More
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
May 22, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action
March 01, 2024
Via
Investor Brand Network
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Quanterix Releases Financial Results for the First Quarter of 2024
May 07, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix To Report First Quarter 2024 Financial Results
April 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
March 21, 2024
From
Quanterix
Via
Business Wire
Earnings Preview: Quanterix
February 28, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
A Preview Of Quanterix's Earnings
February 26, 2024
Via
Benzinga
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
March 04, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
February 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
Earnings Outlook For Quanterix
February 23, 2024
Via
Benzinga
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
Earnings Scheduled For February 26, 2024
February 26, 2024
Via
Benzinga
Quanterix to Present at Cowen’s 44th Annual Health Care Conference
February 23, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
February 16, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 12, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 13, 2023
From
Quanterix Corporation
Via
Business Wire
Sotera Health Appoints Karen Flynn to Board of Directors
November 13, 2023
From
Sotera Health Services, LLC
Via
GlobeNewswire
Quanterix Releases Operating Results for Third Quarter 2023
November 06, 2023
From
Quanterix Corporation
Via
Business Wire
7 Stocks to Buy if You Anticipate a Hot November
November 06, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.